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Postthrombotic syndrome (PTS) is a late outcome of deep vein thrombosis characterized by cramping pain, swelling, hyperpig-
mentation, eczema, lipodermatosclerosis, and ulceration in the leg due to increased venous outﬂow resistance and reﬂux venous
ﬂow. Newer surgical and endovascular interventions have a promising result in the management of postthrombotic syndrome.
Early surgical or endovascular interventions in appropriately selected patients may decrease the incidence of recurrent ulceration
and skin changes and provide a better quality of life. Duplex and IVUS (intravenous ultrasound) along with venography serve as
cornerstoneinvestigative toolsforassessmentofreﬂuxandobstruction.Venous obstruction,ifpresent,shouldbeaddressedearlier
than reﬂux. It requires endovenous stenting, endophlebectomy, or open bypass procedures. Venous stripping, foam sclerotherapy,
radiofrequency, or laser ablation are used to abolish superﬁcial venous reﬂux. Valvuloplasty procedures are useful for incompetent
but intact deep venous valves, while transposition or axillary vein autotransplantation is done for completely destroyed valves.
1.Introduction
Postthrombotic syndrome (PTS) aﬀects nearly 23–60% of
patientsfollowinganepisodeofdeepveinthrombosis(DVT)
[1]. Incidence of venous ulcers is around 3–5% [2]. Develop-
ment of PTS is the principal determinant of health-related
quality of life after DVT [3]. PTS is associated with worse
physical quality of life and increased pain [4]. The annual
health care cost of PTS in the United States is approximately
$200 million [5]. The pathophysiology of PTS involves two
key processes, namely, venous outﬂow obstruction as a re-
sult of partial recanalization of thrombus with decreased
complianceofthrombotic veinandreﬂuxvenous ﬂowdueto
valvular incompetence. Valve station ﬁbrosis leads to luminal
narrowing and valve redundancy or widening of commis-
sural valve angle. These components result in distal venous
stasis and venous hypertension in the lower limb. Reﬂux
occursnotonlyinsegmentsdistaltopostthromboticstenosis
but also in areas remote from them [6].
Work-up includes meticulous clinical history and exam-
ination. Duplex sonography of aﬀected limb has become the
initial investigation of choice. It can qualitatively identify site
of reﬂux and stenosis. Presence of echoic lumen, reduced
compressibility, impaired augmentation of ﬂow on distal
compression, and reduced or absent phasity is qualitative
parameters to identify venous thrombus [7]. Quantitative
assessment of overall severity of reﬂux when multiple seg-
ments are involved can be studied. At present, multisegment
score or presence of axial reﬂux are the best available meas-
ures [8]. Valve closure time has failed to have any clinical
utility [9]. One of the most important drawbacks of duplex
is its inability to properly assess iliac vein thrombus. In-
travascular ultrasound (IVUS ) provides better images of
iliac vein and inferior vena cava thrombi [10]. It is readily
used during stent procedures. Ascending venography is an
invasive method of getting a panoramic view of lower
limb venous outﬂow in infrainguinal area. Eﬃcient collat-
eralization is seen in femoropopliteal postthrombotic steno-
sis via profunda femoris vein. Problem of distal venous
hypertension occurs in iliac vein stenosis due to poor collat-
eral formation in the pelvic veins. This is the reason why ilio-
caval postthrombotic stenosis needs intervention to reduce
theimpactofpostthromboticsyndrome.Ambulatoryvenous
pressure (AVP) provides an overall assessment of venous
dysfunction [11]. AVP is maximum in limbs having venous
obstruction with reﬂux than having either of the two alone.
Investigations like magnetic resonance imaging and com-
puted tomography provide three-dimensional view of the
venous tree.2 Thrombosis
Compression therapy in the form of elastic stockings,
unna boots, have been the traditional method of managing
such patients. High level of noncompliance is a major lim-
iting factor resulting in their failure [12]. Newer devices like
Veinoplus have been tried to provide electrical stimulation
to muscle calf pump. Contractions of calf muscle compress
deep veins and improve the blood ﬂow against resistance,
decrease amount of reﬂux and the amount of venous stasis
[13–15]. These all should be considered complimentary to
newersurgicalandendovasculartechniques.Thetypeofsur-
gical or endovascular intervention depends upon the site and
type of pathology. Venous obstruction, if present, should be
treated earlier than reﬂux [3] with iliofemoral stenting, en-
dophlebectomy,orvenousbypassprocedures.Venousbypass
procedures include crossover bypass or inline bypass proce-
dure. Superﬁcial venous reﬂux is managed earlier than deep
reﬂux with stripping, liquid compression, or foam scle-
rotherapy; endovenous radiofrequency or laser ablation of
saphenous vein. Deep vein valve repair is considered a
second-stage operation when minimally invasive therapies
have failed [3]. Though superﬁcial reﬂux is managed earlier
than deep reﬂux, it has been suggested that both may be
managedconcomitantly[3].Useofbioprostheticvalves(e.g.,
Portland valve), cryopreserved valves, gracilis sling proce-
dure has been largely discouraging [3]. The modiﬁed Ital-
ian neovalve reconstruction seemed to improve valve con-
tinence result signiﬁcantly [16]. Still, strict guidelines or cri-
teriaregardingwhowillbebeneﬁtedmostarenotestablished
[17]. Patients who are considered for surgical or endovascu-
lar interventions include those who had (1) failure of con-
servative therapy, (2) recurrent complications of postthrom-
botic syndrome, and (3) younger population suﬀering with
this syndrome. Stasis skin changes are often the main indica-
tions of surgery [2].
2. Interventions for
Iliofemorocaval Obstruction
2.1. Iliocaval Stenting. It has become the “procedure of
choice” for the management of iliofemorocaval obstruction
[18]. Compared to bypass procedures it is relatively simple,
haslowerrisk,it’sanOPDbasisprocedure,hasexcellentstent
patency and better symptom improvement. Under ultra-
sound guidance, ipsilateral femoral vein is accessed. Iliocaval
thrombus is visualized by IVUS. The stenotic lesions are
dilated by 15-16mm balloon followed by placement of self-
expanding stent. Intraoperative anticoagulation is done with
minimal dose of heparin followed by daily dosage with
aspirin. Gianturco Z stent has been used for stenting wide
calibrevesselslike inferiorvenacava.Wallstenthasbeenused
for inferior vena cava, pelvic veins, and larger veins of
thigh region. For medium-sized vessels, metallic stents with
smaller proﬁle, self-expanding, and longitudinal ﬂexibility
areused.Commonlyuseddiametersare12–14mm.Hartung
et al. found a technical success rate of stenting procedure to
be 95.5% [19]. Venous clinical severity score had a median
improvement from 8.5 to 2, and median venous disability
score improved from 2 to 0. Cumulative primary, assisted
primary,andsecondarypatencyratesofthevenoussegments
at 3 years were 73%, 88%, and 90%, respectively, in intention
to treat. The survival rate was 100% at 1 year and 97.3% at 5
years [19].
2.2. Crossover Bypass Procedure (Palma-Dale Procedure [20]).
These procedures are done in cases of unsuccessful stenting
attempts, stent failure, and long occlusions where stenting
may not be feasible. They are more invasive, risky interven-
tions and require longer anticoagulation therapy. According
to Vollmar [21], prerequisites for success of cross-femoral
grafts are patent contralateral iliofemoral vein and caval
run-oﬀ; a supine resting pressure gradient in excess of 4 to
5mmHg between the femoral veins in the involved and
contralateral limbs; adequate distal venous system (a patent
profunda femoris vein, preferably with an open or partially
recanalized superﬁcial femoral vein ); a patent and compe-
tent greater saphenous vein on the recipient [run-oﬀ]s i d e
with a minimal diameter of 4 to 5mm and no varicosities. In
the crossover bypass, the great saphenous vein of the nonaf-
fectedlimb(donorlimb)isexposedandrotatedatthesaphe-
nofemoral junction. An alternative to the use of autologous
saphenous vein is use of a 10mm PTFE (polytetraﬂuroethy-
lene) graft for femoro-femoral bypass procedure when
adequate calibre saphenous vein is not available. The PTFE
graft is more thrombogenic than the autologous graft. Under
general anaesthesia, vertical incisions are made in both
the groin regions to expose the common femoral, proximal
superﬁcial femoral, profunda femoris vein and other femoral
tributaries. The saphenous vein graft from nonaﬀected limb
is prepared. A deep tunnel in subcutaneous plane is made in
suprapubic and subsartorial region. The saphenous vein is
passed through these tunnels towards the aﬀected side taking
great care to avoid twisting of the vessel. It is anastomosed in
an end to side fashion to the common femoral or proximal
popliteal vein distal to the site of iliofemoral obstruction. An
arteriovenous ﬁstula is made between posterior tibial artery
and vein to increase ﬂow through the graft thus maintaining
graft patency [22] .T h eﬁ s t u l ai su s u a l l yc l o s e d4t o8w e e k s
after surgery. Anticoagulation therapy is given for at least
45 days in the postoperative period. In a study on 78 limbs,
Husni reported a “clinical success” rate of 74% and patency
was 73% during 7 to 144 months of followup [23]. Halliday
et al. reported a cumulative patency rate of 75% during 5 yrs
of followup [24].
2.3. In-Line Bypass Procedure. This procedure may be per-
formed in the femoroiliocaval obstruction associated with
segmental obstruction. Expanded PTFE graft (ePTFE graft)
is most commonly used. An arteriovenous ﬁstula is created
distally to maintain adequate inﬂow. Life-long anticoagula-
tion is usually required. Jost et al. showed a secondary pa-
tency rate of 54% at 2 years [25].
2.4. Endophlebectomy. It is an open surgical technique in
which the postthrombotic vein is longitudinally exposed at
various segments and the synechiae attached to the intimal
layer are carefully removed with scissors at the base. Removal
of the constricting bands increases the inﬂow in iliocaval
stenting and outﬂow for vein valve transposition or transferThrombosis 3
and increase calf outﬂow. Puggioni and Lurie [26]r e p o rt e da
caseseriesof13patientsinwhichsurgicaldisobliterationwas
performed in 23 deep venous segments with 14 deep venous
reconstructions. In 77% of patients, the treated segments
remained primarily patent at mean followup of 11 months.
Overall, secondary patency rate was 93%.
3. Interventions to Correct Venous Reﬂux
Venous reﬂux in PTS can occur at three sites, namely, super-
ﬁ c i a lv e n o u ss y s t e m ,d e e p ,o ra tp e r f o r a t o rl e v e l .T h es u p e r -
ﬁcial reﬂux being easier to manage is attended earlier than
morecomplicateddeepvenousreﬂux.Eveninthepresenceof
concomitant deep venous reﬂux, superﬁcial venous surgery
hasshowntoabolishdeepvenousreﬂuxin50%ofsuchlimbs
and a 77% ulcer healing rate at 12 months [27]. Surgery
for deep venous reﬂux includes valvuloplasty for intact but
incompetent valves, valve transposition, or axillary vein au-
totransplantation for destroyed valves. The ﬁrst open valvu-
loplasty was performed by Dr. Kistner in 1968 [28].
3.1. Ablation of Superﬁcial Venous Reﬂux. Saphenous vein
stripping is still the standard in managing truncal reﬂux in
saphenous vein. Liquid or foam compression sclerotherapy,
endovascular radiofrequency, or laser ablation of the great
saphenous vein have all been used and have been rewarding.
Liquid compression sclerotherapy is eﬀective for cases of
superﬁcial venectasias and nontruncal varicosities with com-
petent great and small saphenous vein [29]. Clinical and he-
modynamic follow-up results have shown that foam scle-
rotherapy is better than liquid compression sclerotherapy
for truncal reﬂux in great saphenous vein [30, 31]. Trials
comparing stripping with endovascularradiofrequencyabla-
tion have shown lesser pain, shorter hospital stay, and earlier
return to work in radiofrequency ablation group. However,
at the end of 4 months, no signiﬁcant diﬀerence was found
in the two groups [32, 33]. Neglen and associates have
combined iliofemoral stenting with obliteration of superﬁ-
cial venous reﬂux and found that it is safe, eﬀective and
minimally invasive single-stage procedure [34]. Ablation of
superﬁcial venous reﬂux along with subcutaneous fasciot-
omy for chronic and recurrent venous ulcers improves ulcer
healing or success of skin grafting [35].
3.2. Interventions for Perforator Incompetence. Role of sur-
gical treatment for perforator incompetence in the man-
agement of PTS has not been studied well. This is because
incompetentperforatorsarerarelyfoundinisolationincases
of postthrombotic syndrome [36]. The incompetent perfo-
rators are treated by SEPS (subfascial endoscopic perforator
surgery) or ultrasound guided therapeutic radiofrequency
ablation.
3.3. Interventions for Deep Venous Reﬂux. The ﬁrst and sec-
ond proximal femoral valve stations are surgically ap-
proached via an ipsilateral groin incision made in the direc-
tion of vessels. Profunda femoris exposure, if required, needs
dissection of sartorius muscle fascia. By performing positive
and negative strip tests, reﬂux at the valve station is assessed.
Reﬂux is demonstrated by venous reﬁlling distally. The ad-
ventitia at the particular valve station is carefully dissected
to expose the valve attachment lines. Failure to identify the
attachment lines implies that the particular valve is com-
pletely destroyed, thus not suitable for valvuloplasty. Either
transposition or autologous vein transfer may be required in
such cases [37].
3.3.1. Internal Valvuloplasty. Following venotomy, the re-
dundantvalvecuspsareexposedandapposedtotheveinwall
under direct vision with the help of 7–0 polypropylene
suture. Plication of approximately 20% of valve length is
usuallysuﬃcient to prevent reﬂux [38]. Dr. Kistner used lon-
gitudinal venotomy approach and opened the valve through
anterior commissure [39]. Other approaches are supravalvu-
lar transverse venotomy without opening the valve [40], T-
shaped venotomy [41]. A novel technique of trapdoor inter-
nal valvuloplasty has been described by Dr. Tripathi and
Ktenidis [42]. After commissure identiﬁcation, transverse
venotomy involving half the circumference is made from
the axis of the centre of one commissure to the other, one
centimetre above andbelow the target valve.With the helpof
specially designed angled retractors, the valve cusps are kept
away from the commissural axis. The anterior ends of the
two transverse venotomy incisions are connected by a longi-
tudinal venotomy along the more anterior of the two com-
missures. This creates a trapdoor at the level of target valve.
It has the beneﬁts of being technically less demanding and
anatomically better deﬁned and physiologically acceptable.
The basic aim of all techniques is one, that is, plication of the
redundant valve.
3.3.2. External Valvuloplasty. This technique involves trans-
mural suturing through the valve attachment lines without
performing a venotomy. It results in narrowing of the com-
missural angles, thus making the valves competent. Several
modiﬁcations have been introduced since long-term results
have shown it to be less durable repair. Limited anterior
plication involves continuous mattress suturing from a point
3 to 4 mm proximal to the valve cusp insertion lines up to
the angle of valve cusp insertion [43]. The aim was to reduce
the amount of vein dissection and reducing the risk of
progressive venous dilatation which occurs in some cases of
valvuloplasty. It has promising long-term follow-up results
in terms of improved venous reﬁlling and decreased ambula-
tory venous pressure [43]. In 1991, Gloviczki and colleagues
[44] described femoral vein valve repair under angioscopic
guidance without performing a venotomy. The angioscope
is introduced through the saphenous vein or one of its trib-
utaries and navigated under vision through the common
femoral vein to the bifurcation of femoral vein. If found
to have primary valvular incompetence, repair of valve is
done by external placement of 7–0 polypropylene sutures.
Suture is placed lateral to the site of insertion of each
valve. The elongated valves are gradually shortened. Valve
competency is checked by infusion of irrigation ﬂuid via the
angioscope. An external PTFE cuﬀ of size 1 to 1.5cm width
is placed around the site of repair to prevent venous dilata-
tion.4 Thrombosis
3.3.3. Transcommissural Valvuloplasty. This technique oﬀers
the advantage of avoiding venotomy as well as need of an
angioscope. Performed in cases of intact but incompetent
valves, it is safe, simple, rapid, and multiple valve stations
can be repaired at the same setting. An inverted V-shape is
formed by the apices of the cusps of bicuspid venous valve.
Afteradventitialdissectionandidentiﬁcationofvalvestation,
a through and through transluminal resuspension suture is
passed obliquely across the inverted “V”, traversing both the
cusps near their attachment to the wall. Involvement of both
the valve cusps is evident by puckering of the valve attach-
ment lines. Further two to four more interrupted stitches are
placed distally, each of them being less deep and less oblique.
The last stitch is at one to two mm beyond the point of
maximum bulge at the valve station. The aim is to shorten
v a l v ec u s pl e n g t ha te a c he n do fc o m m i s s u r eb yn e a r l y2 0 % .
Similar procedure is repeated at the other end of the cusp.
Strip test is performed cautiously to check for valve compe-
tence.Theinternalvalvuloplastycorrectsthevalvecuspsonly
without considering the commissural angles while the exter-
nal valvuloplasty only corrects the commissural angle with-
out considering the valve cusps. The advantage of transcom-
missural valvuloplasty is that it corrects both the redundant
valve cusps as well as commissural angles. The cumulative
competency rates of 140 sites were 84% at 12 months, 72%
at 24 months, and 59% at 30 months [28]. Median time to
failure was 11 to 16 months (range 2–35 months) depending
on the criteria used [28]. Among 36 multiple valves repaired,
duplex scan revealed 11 failures. All 11 valves were single
failures (i.e., only one of the repaired valves in the individual
limb failed, with the other(s) remaining competent) [28].
The cumulative competency rate of the transcommissural
repair is 59% to 69% depending on reﬂux criteria used. It is
comparable to those reported for internal and external repair
[45–47].
3.3.4. Neovalve Reconstruction. The Italian neovalve recon-
struction is a technique of creating an antireﬂux mechanism.
In this technique, the femoral vein is exposed via a 10cm
long longitudinal incision on the lateral border of sartorius
extendingupto10–15cmbelowtheinguinalligament.Intra-
operative identiﬁcation of incompetent valve station is most
crucial though duplex and other preoperative tests may be
used.Alongitudinalortransversevenotomyof2-3cmlength
is performed. With the help of ophthalmic blade or mi-
croscissors, the intimal dissection is performed to raise an
intimalﬂap.Thedepthofdissectiondependsontheveinwall
thickness. A monocuspid or a bicuspid valve can be created
in this fashion. The size of ﬂap is properly assessed to prevent
valve prolapse in case of excessive width. In a variation to the
original technique, Lugli and associates stitched the free edge
of the ﬂap to the vein wall by 7/0 suture [16]. This prevents
reattachment of the ﬂap to the original vein wall that had
resulted in failure of neovalve within a short period after
surgery in earlier series. Contraindications to neovalve re-
construction include severely limited ambulation, throm-
bophilia, bleeding diathesis, severe comorbidity, possibility
of other standard techniques like femoral transposition, or
valve transplant [16]. Cumulative ulcer healing was 7.7/100
patient-months(16casesper206patient-months)intheﬁrst
series and 30.7/100 patient-months (20 cases per 65 patient-
months) in the second [16]. The cumulative patency rates
were 16 cases per 919 patient-months (1.7/100 patient-
months) and 21 per 228 patient-months (9.2/100 patient-
months), respectively, in the ﬁrst and second series [16].
Postoperative duplex scan and air plethysmography mea-
surements showed a signiﬁcant improvement (P<0.001)
[48]. Thus, neovalve reconstruction seemed to be eﬀective in
restoring femoral competence in postthrombotic reﬂux.
3.3.5. Prosthetic Venous Valves. The need for prosthetic ve-
nous valves arises in cases of end-state chronic deep venous
insuﬃciency aﬄicted with recurrent or resistant venous ul-
cerationinwhichtheavailablemedicaltherapyandinterven-
tional procedures like superﬁcial venous ablation or perfora-
tor surgery have failed to provide any clinical or hemody-
namic beneﬁt. Majority of the attempts of prosthetic venous
valve repair have not shown good results. A bioprosthetic
Portland valve (bicuspid square stent -based venous valve
made from small intestinal submucosa) has been studied
after percutaneous placement in the sheep external jugular
vein [49]. It has 88% patency and competency rate. Valve
tilting led to occlusion and valve insuﬃciency in three exper-
imental animals [49]. Variations have been made to prevent
tilting and to provide a longer cusp which is supposed to
bemorehemodynamicstructure.Valvethickeningisanother
problem with the prosthetic valves. Cryopreserved valves are
superﬁcial femoral vein containing valve allograft made by
Cryo Life, Inc, Kennesaw, Georgia. They can prevent venous
reﬂux up to 125mmHg of retrograde venous pressure. They
may require valvuloplasty at the time of implantation for
optimal performance and competency [50]. The cryopre-
served valve allografts have failed in early and midterm
clinical trial and are not considered suitable for treating DVT
[51]. Graft rejection is a concerning issue regarding graft
failure. T-cell immunosuppressive drugs like cyclosporine
and azathioprine may prevent graft rejection. Another tech-
nique of restoring deep venous valve competence involves
intussusceptionoftheveinintoitself[52].Thebicuspidvalve
is made by two sutures placed at 180 degree to hold the
inner vein wall in correct position. Short-term patency was
good with competency rate of 90–100%. But hemodynamic
results are not as fair as in the case of native valves. Mod-
iﬁcations like thinning of the adventitia and partly of the
media to decrease the thickness of these valves have been
done and studied in canine model [53]. Problem of valve
thrombosis is a limiting factor in prosthetic valve as com-
pared to native valves. Repopulating a decellularized external
vein containing valve allograft with donor smooth muscle
cells and endothelial cells has been attempted to make the
transplant quite similar to an autogenous vein in sheep ex-
periments [54]. 75% of the valves (nine out of twelve) were
patent and competent at 12 weeks. Two were aﬀected by the
neointimal growth and one had occluded [54]. Use of Z-type
stent conﬁguration with metal exoskeleton and a vein con-
taining the valve lining inside has been used. The Z-con-
ﬁguration allows expansion in the area of valve which isThrombosis 5
consideredessentialforpropervalvecleansingandlong-term
function [55].
3.3.6. Axillary Vein Autotransplantation. First described in
humans by Taheri in 1982 [56], this procedure is done in
cases of deep venous reﬂux with destroyed valves. A 2-3cm
of axillary vein segment containing a competent valve or a
reparable one is removed. The femoral vein is accessed, and
the segment containing the incompetent valve is removed.
Presence of intraluminal synechiae in the femoral vein near
the site of anastomosis requires excision to create a sizeable
lumen for proper anastomosis [57]. If the axillary vein valve
explant is incompetent (as seen in 40% of the axillary vein
explants), a bench repair by transcommissural external valv-
uloplasty technique is done before anastomosis [37, 38].
With the help of interrupted sutures, the proximal anasto-
mosis of femoral vein with the axillary vein segment is per-
formed. Proximal anastomosis is done earlier than the distal
anastomosis as this allows to check for valvular competence
and causes distension and lengthening of the axillary vein
segment, thus facilitating better distal anastomosis. An exter-
nal PTFE sleeve is placed over the axillary vein graft and
secured in position by adventitial stitches. It prevents future
dilatation of the graft segment.
3.3.7. Valve Transposition. It is a technique in which the in-
competent venous system with destroyed valves is placed dis-
tal to the competent valve. Prerequisite for this procedure is
that at least a single axial venous valve in the groin area is
competent. Examples include transaction of incompetent
femoral vein and reimplantation distal to the competent
valve in the profunda femoris vein or distal to the competent
great saphenous vein. Similarly, the incompetent profunda
femoris vein can be transposed distal to the competent fem-
oral vein valve. From the results of using the ipsilateral great
saphenous vein transposition, it has been found to be safe
and eﬀective with good mid-term results, especially for pain.
For ulcers, the primary success rate was 55% but it increased
to 84% with proper surveillance and treatment of secondary
insuﬃciency of the superﬁcial venous system [58].
4. Conclusion
Postthrombotic syndrome is a challenging complication of
deep vein thrombosis requiring multimodal approach for
appropriate management. Prevention is better than cure
holds true in this case. Identiﬁcation of patients at risk for
deepveinthrombosisisessential.PreventionofDVTinthese
high groups by using mechanical and chemoprophylaxis
agents is required to decrease the incidence and complica-
tions of postthrombotic syndrome. Though many surgical
options have been described, they are performed only at
selectedcentresandarenotfullproof.Theﬁrstlineandeasily
available management includes use of graduated compress
ion stockings, pneumatic compression devices, oral and in-
jectable anticoagulants. Surgery or endovascular therapy, if
feasible, should be considered complementary to medical
management. Venous outﬂow obstruction is treated earlier
than venous reﬂux. Superﬁcial venous reﬂux is managed
before treatment of deep venous reﬂux. Surgical manage-
ment is a more deﬁnitive treatment than the conservative
treatment.
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